Skip to main content
. 2021 Jun 19;26(12):3744. doi: 10.3390/molecules26123744

Table 1.

Therapeutic schemes received by each group.

GROUPS PD-1 OX40 PD-1+OX40 VTP VTP+PD-1 VTP+OX40 VTP+OX40+PD-1 CONTROL
INTERVENTION
Antibody anti OX-40 X X X X
Antibody anti-PD-1 X X X X
VTP * X X X X
NO INTERVENTION X

* Vascular Target Photodynamic therapy (150J).